Different Phenotypes of Hidradenitis Suppurativa
Dermatologic Clinics · 2025-04 · 43 (2) · 155-171
DOI: 10.1016/j.det.2024.12.002 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Dermatologic Clinics, 2025-04. Verfasst von Vahide Saeidi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Mayo Clinic School of Graduate Medical Education, Mayo Clinic College of Medicine and Science, 200 First Street SW, Roches…. Hauptthemen laut MEDLINE: Hidradenitis Suppurativa. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 93 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Mayo Clinic School of Graduate Medical Education, Mayo Clinic College of Medicine and Science, 200 First Street SW, Rochester, MN 55905, USA.
- Department of Dermatology, Erasmus Medical Center, Dr Molewaterplein 50, EE-802, Rotterdam, CA 3000, The Netherlands.
- Psoriasis Research and Treatment Center, Department of Dermatology, Venereology & Allergology and Institute of Medical Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and H…
- Department of Dermatology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. Electronic address: Alavi.Afsaneh@mayo.edu.
Zitieren
APA
Saeidi, V., Van der Zee, H., Sabat, R., & Alavi, A. (2025). Different Phenotypes of Hidradenitis Suppurativa. Dermatologic Clinics, 43(2), 155-171. https://doi.org/10.1016/j.det.2024.12.002
Vancouver
Saeidi V, Van der Zee H, Sabat R, Alavi A. Different Phenotypes of Hidradenitis Suppurativa. Dermatologic Clinics. 2025;43(2):155-171. doi:10.1016/j.det.2024.12.002
BibTeX
@article{Saeidi2025,
author = {Saeidi, Vahide and Van der Zee, Hessel and Sabat, Robert and Alavi, Afsaneh},
title = {Different Phenotypes of Hidradenitis Suppurativa},
journal = {Dermatologic Clinics},
year = {2025},
volume = {43},
number = {2},
pages = {155--171},
doi = {10.1016/j.det.2024.12.002}
}
EUVIMED